Tablet Dedusters Are Flexible and Efficient - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Tablet Dedusters Are Flexible and Efficient


Vertical tablet conveyors/dedusters have become an economical way to efficiently convey and dedust vitamin and nutraceutical tablets using a small footprint. The Kraemer KD60 series vertical vibratory conveyor uses gentle vibration to dedust and convey the product quietly (less than 70 db) upward in a spiral along a smooth, perforated surface (0.3 µm Ra surface roughness). A window gives full view and access to see the tablet movement up the helix.
 
Inlet and outlet orientation is adjusted easily without tools, and the stand height adjusts to meet press requirements. The all stainless-steel construction, cGMP design, and tool-less disassembly allow for easy cleaning in full compliance with FDA standards. The C820 controller with integrated acceleration sensor allows for a constant flow of tablets under varying tablet loads. The conveyor/deduster can be configured with an integral metal detector.

Source: Kraemer US

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy

Click here